Alto Neuroscience, Inc.
ANRO· NYSE
Released Mar 16, 2026, before the open
10-K filed Mar 16, 2026, 75 days after period end · 0001999480-26-000002
derived · Computed from the longer spans the company filed.
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures |
|---|---|---|---|
| Net Income | -$16.18M | -$15.20M | -$11.22M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Alto Neuroscience, Inc. · CIK 1999480 · Engraved from SEC EDGAR
ended Dec 31, 2025 · filed Mar 16, 2026 · 75 d after period end
+8.2% from the close of Mar 13, 2026 to the close of Mar 16, 2026, the first after the release.